Samsung Biologics presents 2024 business plans at J.P. Morgan Healthcare Conference

INCHEON, South Korea, Jan. 9, 2024 /PRNewswire/ — Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today presented its 2024 business plans and strategy at the J.P. Morgan Healthcare Conference held in San Francisco, California….

Click here to view original post